Low-dose Aminophylline Combined with Protein Nutrition Improves Lung Function and Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease
Low-dose aminophylline treatment can not only regulate the body's immune function, but also reduce adverse drug reactions. Aminophylline is a bronchodilator, which can reduce adenylate phosphodiesterase activity after oral administration, reduce its effect on the bronchus, and improve the symptoms of dyspnea in patients. This article analyzes low-dose aminophylline combined with protein nutrition to improve lung function and exercise tolerance in patients with chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease (COPD) is a chronic disease with major clinical symptoms due to restricted airflow and persistent cough, sputum, shortness of breath, or dyspnea. It is manifested by chronic hypoxemia and a progressive increase in carbon dioxide retention Respiratory diseases. COPD has a high prevalence and a long course of disease, which seriously affects the physical and mental health of patients. Glucocorticoids are common drugs in the clinical treatment of COPD, which can relieve clinical symptoms, but when used alone, they cannot improve the clinical symptoms of patients in the short term. Low-dose aminophylline combined with protein nutrition for COPD can improve the anti-inflammatory effect, improve bronchial smooth muscle spasm, alleviate the symptoms of dyspnea, and improve exercise tolerance. It is worth promoting.